Bayer CropScience and Scivax Corporation sign research cooperation and exclusive license option | Checkbiotech

Home | Contact Us | Partnership | Site Map

left shadow

Checkbiotech - for emerging fields of science

NEWSLETTERS SUBMIT CONTENT

Checkbiotech Home

Sign In | Register

bottom shadow


	View Edit Domain: GreenBio Title: * Body: Bayer CropScience and the biotech company Scivax Corporation, Kawasaki, Japan, have entered into a cooperation on yield enhancement under abiotic stress conditions in plants, initially in cotton. <br /> <br /> Under the terms of this agreement, Bayer CropScience will sponsor and support Scivax’s Research & Development (R&D) activities in these traits for the next three years. In turn, Scivax grants Bayer CropScience an option to obtain a worldwide, exclusive license to their patent portfolio for use in crops. Financial details of the agreement were not disclosed.<br /> <br /> Scivax has been developing technologies for enhanced yield since 2005 under collaboration with Professor Teruhiro Takabe of Meijo University and Professor Tetsuko Takabe of Nagoya University. The company has demonstrated the value of their technology under abiotic stress conditions in greenhouse <a href="http://www.goarticles.com/cgi-bin/showa.cgi?C=2453038">acai berry weight loss </a> trials with a variety of crops. Scivax and Bayer will now join forces to further optimize the technology.<br /> <br /> Dr. Linda Trolinder, Global Cotton R&D Manager at BioScience, a business operations unit of Bayer CropScience, welcomes this business relationship with Scivax. “At Bayer CropScience, we strive to be the global innovation leader in cotton and are investing significantly in the development of valuable new solutions for farmers to help them be more productive and profitable. We anticipate that Scivax’ innovative technology will contribute to further strengthening our competitive position in the global cotton market, especially with regard to ensuring higher yields in difficult climatic conditions.”<br /> <br /> “We are excited about this collaboration with Bayer CropScience, an established innovator and global leader in agribusiness,” said Norimichi Okuda, Vice President at Scivax Corporation. “We are looking forward to our relationship to develop valuable <a href="http://www.51acaiberry.com/">acai berry products</a> utilizing our yield enhancement and abiotic stress improvement technology.”<br /> <br /> <strong>About Bayer CropScience</strong><br /> <br /> Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.4 billion (2008), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. The company offers an outstanding range of products and extensive <a href="http://www.10jun.com/">consumer reviews</a> service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of more than 18,000 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.<br /> <br /> <strong>About Scivax</strong><br /> <br /> Scivax Corporation is a R&D venture company and a unique solution provider in the field of biotechnology and nanotechnology. Scivax focuses on bridging between science seeds in Universities/National laboratories and industrialization in different area. Scivax has more than 20 skilled specialists of not only biotechnology but also different field such as mechanical engineering, material science, etc. Further information is available at www.scivax.com.<br /> <br /> <strong>Contact:</strong><br /> <br /> Richard Breum, phone: +49 2173 38-3270<br /> E-mail: richard.breum@bayercropscience.com<br /> <br /> <strong>Forward-Looking Statements</strong><br /> <br /> <em>This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.</em><br /> <br /> Copyright 2009 Bayer CropScience<br /> Captcha: Please Enter Code : * Time Zone: * Select the time zone Vocabularies Newsletter: Domain: Show summary in full view Input format Filtered HTML Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically. Full HTML Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically. news_filter Web page addresses and e-mail addresses turn into links automatically. More information about formatting options			Related Articles Syngenta and Bayer CropScience Sign Global Cotton Technology... Arkansas jurors hear opening statements in rice trial Bayer CropScience and the International Rice Research Instit... Farmers face off with chemical maker over rice More GMO crop propagation seen New study reignites debate over GMO safety United Potato Growers of America and Bayer CropScience conti... Genetically modified rice leads to ruling against Bayer Crop... Unseen harvest of gene war on billion-dollar pest Rice contamination suit gets underway in St. Louis Top GreenBio Articles

Home | Partnership | Contact Us | Site Map | News Site Map
© 2000-2012 Checkbiotech.org | Disclaimer